Insmed shares double as lung drug data convince Wall Street
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Stephen Willey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen's First Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.
GERN earnings call for the period ending March 31, 2024.
GERN earnings call for the period ending December 31, 2023.
GERN earnings call for the period ending December 31, 2023.